What's New in Genetic Skin Diseases?

In a recent presentation by Nessa Gazza, a pediatric dermatologist from the Mayo Clinic, the advancements in treating genetic skin diseases were discussed through various patient case studies. The talk emphasized how understanding genetic mutations and employing targeted therapies have radically improved patient outcomes. One case involved a young girl with refractory psoriasis who was diagnosed with a CARD 14-associated mutation. After targeting her treatment with specific biologics, her condition dramatically improved. In another example, a 30-year-old woman suffering from Olmsted syndrome was treated with an epidermal growth factor receptor inhibitor, leading to significant relief from debilitating symptoms. A third case featured an elderly woman diagnosed with epidermolysis bullosa, where dupilumab was utilized to address her pruritus effectively. Lastly, the complexities of managing nevoid basal cell carcinoma syndrome were tackled. Despite long-term use of smoothened inhibitors causing significant side effects, alternatives such as intermittent dosing and the switch to sonidegib showed promise, while minoxidil was suggested to help with hair loss. Overall, the talk highlighted the crucial role of genetic testing and personalized treatments in enhancing the quality of life for patients with these challenging skin conditions.